HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complicated silicotuberculosis in a South African gold miner: A case report.

Abstract
We present a case of complicated silicotuberculosis in a former gold miner with a sufficiently heavy silica dust exposure to cause International Labor Organization grade 2/2 silicosis after a cumulative exposure duration of 11 years. We describe a cascade of complications-active pulmonary tuberculosis despite recent isoniazid prophylactic therapy, non-tuberculous mycobacterial disease, chronic airways obstruction, and spontaneous pneumothorax-and the difficulties, which arose, in diagnosis and management of such combined disease. We highlight three implications of such cases: the need to understand the interaction of silicosis and tuberculosis in this setting, the importance of maintaining continuity of care in the management of these conditions in miners and former miners, and control of silica dust exposure as a primary form of prevention of tuberculosis.
AuthorsTolu Oni, Rodney Ehrlich
JournalAmerican journal of industrial medicine (Am J Ind Med) Vol. 58 Issue 6 Pg. 697-701 (Jun 2015) ISSN: 1097-0274 [Electronic] United States
PMID25914322 (Publication Type: Case Reports, Journal Article)
Copyright© 2015 Wiley Periodicals, Inc.
Chemical References
  • Antitubercular Agents
  • Dust
  • Gold
  • Silicon Dioxide
  • Isoniazid
Topics
  • Antitubercular Agents (therapeutic use)
  • Continuity of Patient Care
  • Dust
  • Gold
  • Humans
  • Isoniazid (therapeutic use)
  • Male
  • Middle Aged
  • Miners
  • Mining
  • Mycobacterium Infections, Nontuberculous (etiology)
  • Occupational Exposure (prevention & control)
  • Pneumothorax (etiology)
  • Post-Exposure Prophylaxis
  • Pulmonary Disease, Chronic Obstructive (etiology)
  • Silicon Dioxide (toxicity)
  • Silicotuberculosis (complications, therapy)
  • South Africa

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: